Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02128997 · ClinicalTrials.gov registry record · NA
PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population
A NA study of Wound Complication, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
- 1
- Study location
NCT02128997: Completed NA study of Wound Complication, sponsored by University of Pennsylvania.
NCT02128997 is a NA study of Wound Complication that has completed, run by University of Pennsylvania. The registered enrollment target is 136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02128997, a NA study of Wound Complication, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess whether a negative pressure wound vacuum therapy (NPWT) on closed incisions decreases the risk of wound complications among obese patients after cesarean section All patients having a cesarean section in labor or presenting to the triage unit and requiring a cesarean section will be eligible Main study intervention: this involves the use of a negative pressure wound vacuum therapy on a closed incision.
Primary Outcome
The primary outcome variable was a composite of wound morbidity at 4 weeks postpartum including SSI and/or wound opening
Conditions Studied
Interventions
- DEVICE Closed incision wound vacuum (Prevena)
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2014-05 |
| Est. Completion | 2017-08 |
| Phase | NA |
What the finished NCT02128997 record still lists
NCT02128997 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Wound Complication appearing as the primary indexed condition, and to 1 intervention - of which Closed incision wound vacuum (Prevena) is the first listed.
NCT02128997 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02128997 about?
NCT02128997 is a clinical study titled "PROphylactic Wound VACuum Therapy to Decrease Rates of Cesarean Section in the Obese Population". This study will assess whether a negative pressure wound vacuum therapy (NPWT) on closed incisions decreases the risk of wound complications among obese patients after cesarean section All patients having a cesarean section in labor or presenting to the triage unit and requiring a cesarean section ...
What is the current status of trial NCT02128997?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2014-05. Estimated completion is 2017-08.
What conditions does trial NCT02128997 study?
This clinical trial studies the following conditions: Wound Complication.
What interventions are being tested in trial NCT02128997?
The interventions under investigation include: Closed incision wound vacuum (Prevena) (DEVICE).
Who is sponsoring clinical trial NCT02128997?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02128997 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Complication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02128997's enrollment target sits among peer trials
136 722nd of 2000 higher than 1,275 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia